| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Northwest Biotherapeutics Inc (OTCQB: NWBO)
NWBO Technical Analysis
5
| As on 12th Nov 2024 NWBO SHARE Price closed @ 0.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.64 & Strong Sell for SHORT-TERM with Stoploss of 0.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NWBOSHARE Price
| Open | 0.32 | Change | Price | % |
| High | 0.33 | 1 Day | -0.01 | -3.12 |
| Low | 0.29 | 1 Week | 0.04 | 14.81 |
| Close | 0.31 | 1 Month | -0.01 | -3.12 |
| Volume | 2273300 | 1 Year | -0.27 | -46.55 |
| 52 Week High 1.04 | 52 Week Low 0.26 | ||||
OTCQB USA Most Active Stocks
| FNMA | 2.34 | -13.33% |
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| CBDS | 0.05 | -37.50% |
| FMCC | 2.30 | -13.53% |
| BTCWF | 0.10 | 150.00% |
| EFSH | 0.35 | -14.63% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| NWBO Daily Charts |
NWBO Intraday Charts |
Whats New @ Bazaartrend |
NWBO Free Analysis |
|
|
NWBO Important Levels Intraday
| RESISTANCE | 0.39 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.35 |
| RESISTANCE | 0.33 |
| SUPPORT | 0.29 |
| SUPPORT | 0.27 |
| SUPPORT | 0.26 |
| SUPPORT | 0.23 |
NWBO Forecast December 2024
| 4th UP Forecast | 0.81 |
| 3rd UP Forecast | 0.65 |
| 2nd UP Forecast | 0.55 |
| 1st UP Forecast | 0.45 |
| 1st DOWN Forecast | 0.17 |
| 2nd DOWN Forecast | 0.07 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.19 |
NWBO Weekly Forecast
| 4th UP Forecast | 0.41 |
| 3rd UP Forecast | 0.38 |
| 2nd UP Forecast | 0.36 |
| 1st UP Forecast | 0.34 |
| 1st DOWN Forecast | 0.28 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | 0.24 |
| 4th DOWN Forecast | 0.21 |
NWBO Forecast2024
| 4th UP Forecast | 1.93 |
| 3rd UP Forecast | 1.41 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.77 |
| 1st DOWN Forecast | -0.15 |
| 2nd DOWN Forecast | -0.47 |
| 3rd DOWN Forecast | -0.79 |
| 4th DOWN Forecast | -1.31 |
Northwest Biotherapeutics Inc ( OTCQB USA Symbol : NWBO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NWBO Business Profile
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L that is in Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Address: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service